Renal mucormycosis following COVID-19 treatment with immune modulators: a case report

Deepak Chaudhary; Ashish  Behera; Navneet Sharma

doi:10.18502/fem.v6i1.7684

Deepak Chaudhary Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Ashish Behera Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Navneet Sharma Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

DOI: https://doi.org/10.18502/fem.v6i1.7684

Keywords: Case Reports; COVID-19; Immunosuppression; Mucormycosis; Renal Insufficiency

Abstract

Mucormycosis is an opportunistic fungal infection that occurs primarily in immunocompromised individuals, usually affecting the rhino-orbital areas followed by the lungs. This case report presents renal mucormycosis in a young man after COVID-19 pneumonia that escalates the need for regular follow-up of COVID-19 patients. Post-COVID-19 fungal infections are on a steep rise, and the increased use of steroids and immune modulators for COVID-19-associated immune dysregulation and cytokine syndrome increases the risk among patients treated for COVID-19.